Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy

Not yet recruiting · NCT07718737 · Registry updated 2026-08-10

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Not yet recruiting	Phase 2 / Phase 3	2026-08-10		NCT07718737

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Multitude Therapeutics Inc.	7

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Austin Health (Olivia Newton John Cancer Centre)	Melbourne	Australia	1
Calvary Mater Newcastle	Newcastle	Australia	1
Coffs Harbour Health Campus	Coffs Harbour	Australia	2
Hematology Oncology Associates of the Treasure Coast	Port Saint Lucie	United States	8
Lumi Research	Kingwood	United States	11
Macquarie University Hospital	Sydney	Australia	4
St Vincent's Hospital Melbourne	Melbourne	Australia	3